These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 28164592)

  • 1. Diagnostic Efficiency of Serum and Urine Procathepsin B and Cathepsin B in Patients with Carcinoma of the Urinary Bladder.
    Dusek P; Kotaska K; Vesely S; Prusa R; Babjuk M
    Clin Lab; 2016 Sep; 62(9):1709-1715. PubMed ID: 28164592
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urine and serum cathepsin B concentrations in the transitional cell carcinoma of the bladder.
    Kotaska K; Dusek P; Prusa R; Vesely S; Babjuk M
    J Clin Lab Anal; 2012 Feb; 26(2):61-5. PubMed ID: 22467319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cathepsins B, H, and L activities in urine of patients with transitional cell carcinoma of the bladder.
    Staack A; Koenig F; Daniltchenko D; Hauptmann S; Loening SA; Schnorr D; Jung K
    Urology; 2002 Feb; 59(2):308-12. PubMed ID: 11834417
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Podoplanin serum and urine concentration in transitional bladder cancer.
    Sankiewicz A; Guszcz T; Mena-Hortelano R; Zukowski K; Gorodkiewicz E
    Cancer Biomark; 2016; 16(3):343-50. PubMed ID: 26835590
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of urinary cathepsin B and L in the detection of bladder urothelial cell carcinoma.
    Svatek RS; Karam J; Karakiewicz PI; Gallina A; Casella R; Roehrborn CG; Shariat SF
    J Urol; 2008 Feb; 179(2):478-84; discussion 484. PubMed ID: 18076936
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cathepsin B levels in urine from bladder cancer patients.
    Eiján AM; Sandes E; Puricelli L; Bal De Kier Joffé E; Casabé AR
    Oncol Rep; 2000; 7(6):1395-9. PubMed ID: 11032951
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urine laminin P1 assessment discriminates between invasive and noninvasive urothelial cell carcinoma of the bladder.
    Abou Farha KM; Menheere PP; Nieman FH; Janknegt RA; Arends JW
    Urol Int; 1993; 51(4):204-8. PubMed ID: 8266611
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic value of neutrophil gelatinase-associated lipocalin/matrix metalloproteinase-9 pathway in transitional cell carcinoma of the bladder.
    Candido S; Di Maso M; Serraino D; McCubrey JA; Bortolus R; Zanin M; Battiston M; Salemi R; Libra M; Polesel J
    Tumour Biol; 2016 Jul; 37(7):9855-63. PubMed ID: 26810191
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of serum procathepsin B, cystatin B and cystatin C as possible biomarkers of ovarian cancer.
    Gashenko EA; Lebedeva VA; Brak IV; Tsykalenko EA; Vinokurova GV; Korolenko TA
    Int J Circumpolar Health; 2013; 72():. PubMed ID: 23986888
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urinary levels of tumor-associated trypsin inhibitor (TATI) in the detection of transitional cell carcinoma of the urinary bladder.
    Shariat SF; Herman MP; Casella R; Lotan Y; Karam JA; Stenman UH
    Eur Urol; 2005 Sep; 48(3):424-31. PubMed ID: 15963628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced urinary gelatinase activities (matrix metalloproteinases 2 and 9) are associated with early-stage bladder carcinoma: a comparison with clinically used tumor markers.
    Sier CF; Casetta G; Verheijen JH; Tizzani A; Agape V; Kos J; Blasi F; Hanemaaijer R
    Clin Cancer Res; 2000 Jun; 6(6):2333-40. PubMed ID: 10873084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum and urine ferritin in patients with transitional cell carcinoma of the bladder.
    Migliari R; Mela Q; Ruggiero V; Scarpa RM; Migliari M; Pitzus F; Usai E
    Arch Ital Urol Nefrol Androl; 1991 Mar; 63(1):141-5. PubMed ID: 1830406
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New electrochemiluminescent immunoassay for the determination of CYFRA 21-1: analytical evaluation and clinical diagnostic performance in urine samples of patients with bladder cancer.
    Sánchez-Carbayo M; Espasa A; Chinchilla V; Herrero E; Megías J; Mira A; Soria F
    Clin Chem; 1999 Nov; 45(11):1944-53. PubMed ID: 10545064
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased accuracy of a novel mRNA-based urine test for bladder cancer surveillance.
    Pichler R; Fritz J; Tulchiner G; Klinglmair G; Soleiman A; Horninger W; Klocker H; Heidegger I
    BJU Int; 2018 Jan; 121(1):29-37. PubMed ID: 28941000
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor-associated trypsin inhibitor as a prognostic factor during follow-up of bladder cancer.
    Kelloniemi E; Rintala E; Finne P; Stenman UH;
    Urology; 2003 Aug; 62(2):249-53. PubMed ID: 12893328
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CXCL5 is a potential diagnostic and prognostic marker for bladder cancer patients.
    Zhu X; Qiao Y; Liu W; Wang W; Shen H; Lu Y; Hao G; Zheng J; Tian Y
    Tumour Biol; 2016 Apr; 37(4):4569-77. PubMed ID: 26503215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urinary level of CA19-9 as a tumor marker in urothelial carcinoma of the bladder.
    Pal K; Roy S; Mondal SA; Chatterjee U; Tiwari P; Bera M
    Urol J; 2011; 8(3):203-8. PubMed ID: 21910099
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of CD147, BIGH3 and Stathmin and their potential role as diagnostic marker in patients with urothelial carcinoma of the bladder.
    Bhagirath D; Abrol N; Khan R; Sharma M; Seth A; Sharma A
    Clin Chim Acta; 2012 Oct; 413(19-20):1641-6. PubMed ID: 22626996
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Initial evaluation of CYFRA 21-1 diagnostic performances as a urinary marker in bladder transitional cell carcinoma.
    Pariente JL; Bordenave L; Michel P; Latapie MJ; Ducassou D; Le Guillou M
    J Urol; 1997 Aug; 158(2):338-41. PubMed ID: 9224298
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the nuclear matrix protein 22 with voided urine cytology and BTA stat test in the diagnosis of transitional cell carcinoma of the bladder.
    Sözen S; Biri H; Sinik Z; Küpeli B; Alkibay T; Bozkirli I
    Eur Urol; 1999 Sep; 36(3):225-9. PubMed ID: 10450007
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.